Moberg Derma Company
Moberg Pharma is a rapidly growing Swedish pharmaceutical company that commercializes proprietary, acquired and licensed products in the global market. They create value for patients, physicians and owners by offering products based on proven compounds, which have better efficacy, fewer side effects or are easier to use. Initially, Moberg Pharma specialized in the treatment of skin diseases but is now widening its scope to include additional areas. They market OTC brands in the U.S. and sell through distributors in more than 35 countries.
Technology:
Specific disorder-related
Industry:
Treatment range
Headquarters:
Bromma, Sweden
Founded Date:
01.01.2006
Employees Number:
1-10
Funding Status:
IPO
Total Funding:
$4 036 518
Estimated Revenue:
$0
Last Funding Date:
28.06.2007
Last Funding Type:
Series B
Register and Claim Ownership